The cerebrovascular basement membrane: Role in the clearance of β-amyloid and cerebral amyloid angiopathy

Frontiers in Aging Neuroscience

Volumn 6, Issue SEP, 2014, Pages

  Morris, Alan W J ^a   Carare, Roxana O ^a   Schreiber, Stefanie ^b,c   Hawkes, Cheryl A ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

^c GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

Author keywords

Alzheimer's disease; Basement membrane; Cerebral amyloid angiopathy; Perivascular drainage; amyloid

Indexed keywords

AMYLOID BETA PROTEIN;

ALZHEIMER DISEASE; ANGIOGENESIS; BASEMENT MEMBRANE; BIOCHEMICAL COMPOSITION; BLOOD VESSEL PARAMETERS; BRAIN BLOOD FLOW; BRAIN BLOOD VESSEL; BRAIN FUNCTION; BRAIN REGION; CEREBROVASCULAR BASEMENT MEMBRANE; DISEASE SEVERITY; EXTRACELLULAR MATRIX; HUMAN; INTERSTITIAL FLUID; METABOLIC PARAMETERS; MORPHOLOGY; NONHUMAN; PARENCHYMA; PLASMA CLEARANCE; REVIEW; SIGNAL TRANSDUCTION; SOLUTE; VASCULAR AMYLOIDOSIS; VASCULARIZATION;

EID: 84907222721     PISSN: None     EISSN: 16634365     Source Type: Journal    
DOI: 10.3389/fnagi.2014.00251     Document Type: Review

References (120)

1. Abbott, N. J. (2004). Evidence for bulk flow of brain interstitial fluid: significance for physiology and pathology. Neurochem. Int. 45, 545-552. doi:10.1016/j.neuint.2003.11.006
2. Alafuzoff, I., Arzberger, T., Al-Sarraj, S., Bodi, I., Bogdanovic, N., Braak, H., et al. (2008). Staging of neurofibrillary pathology in Alzheimer's disease: a study of the BrainNet Europe Consortium. Brain Pathol. 18, 484-496. doi:10.1111/j.1750-3639.2008.00147.x
3. Aletrino, M. A., Vogels, O. J., Van Domburg, P. H., and Ten Donkelaar, H. J. (1992). Cell loss in the nucleus raphes dorsalis in Alzheimer's disease. Neurobiol. Aging 13, 461-468. doi:10.1016/0197-4580(92)90073-7
4. Alzheimer's Disease International. (2014). Dementia Statistics. Available from: http://www.alz.co.uk/research/statistics
5. Arbel-Ornath, M., Hudry, E., Eikermann-Haerter, K., Hou, S., Gregory, J. L., Zhao, L., et al. (2013). Interstitial fluid drainage is impaired in ischemic stroke and Alzheimer's disease mouse models. Acta Neuropathol. 126, 353-364. doi:10.1007/s00401-013-1145-2
6. Aumailley, M., Bruckner-Tuderman, L., Carter, W. G., Deutzmann, R., Edgar, D., Ekblom, P., et al. (2005). A simplified laminin nomenclature. Matrix Biol. 24, 326-332. doi:10.1016/j.matbio.2005.05.006
7. Aumailley, M., and Krieg, T. (1996). Laminins: a family of diverse multifunctional molecules of basement membranes. J. Invest. Dermatol. 106, 209-214. doi:10.1111/1523-1747.ep12340471
8. Bader, B. L., Smyth, N., Nedbal, S., Miosge, N., Baranowsky, A., Mokkapati, S., et al. (2005). Compound genetic ablation of nidogen 1 and 2 causes basement membrane defects and perinatal lethality in mice. Mol. Cell. Biol. 25, 6846-6856. doi:10.1128/MCB.25.15.6846-6856.2005
9. Barber, A. J., and Lieth, E. (1997). Agrin accumulates in the brain microvascular basal lamina during development of the blood-brain barrier 23. Dev. Dyn. 208, 62-74.
10. Barua, N. U., Bienemann, A. S., Hesketh, S., Wyatt, M. J., Castrique, E., Love, S., et al. (2012). Intrastriatal convection-enhanced delivery results in widespread perivascular distribution in a pre-clinical model. Fluids Barriers CNS 9, 2. doi:10.1186/2045-8118-9-2
11. Begley, D. J., Squires, L. K., Zlokovic, B. V., Mitrovic, D. M., Hughes, C. C., Revest, P. A., et al. (1990). Permeability of the blood-brain barrier to the immunosuppressive cyclic peptide cyclosporin A. J. Neurochem. 55, 1222-1230. doi:10.1111/j.1471-4159.1990.tb03128.x
12. Bell, R. D., Winkler, E. A., Sagare, A. P., Singh, I., LaRue, B., Deane, R., et al. (2010). Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging. Neuron 68, 409-427. doi:10.1016/j.neuron.2010.09.043
13. Berzin, T. M., Zipser, B. D., Rafii, M. S., Kuo-Leblanc, V., Yancopoulos, G. D., Glass, D. J., et al. (2000). Agrin and microvascular damage in Alzheimer's disease. Neurobiol. Aging 21, 349-355. doi:10.1016/S0197-4580(00)00121-4
14. Bird, T. D., and Miller, B. L. (2007). Dementia, 17 Edn. Columbus, OH: McGraw-Hill.
15. Boche, D., Zotova, E., Weller, R. O., Love, S., Neal, J. W., Pickering, R. M., et al. (2008). Consequence of Abeta immunization on the vasculature of human Alzheimer's disease brain. Brain 131(Pt 12), 3299-3310. doi:10.1093/brain/awn261
16. Bondareff, W., Mountjoy, C. Q., and Roth, M. (1982). Loss of neurons of origin of the adrenergic projection to cerebral cortex (nucleus locus ceruleus) in senile dementia. Neurology 32, 164-168. doi:10.1212/WNL.32.2.164
17. Braak, H., and Braak, E. (1991). Neuropathological staging of Alzheimer-related changes. Acta Neuropathol. 82, 239-259. doi:10.1007/BF00308809
18. Braak, H., Braak, E., Grundke-Iqbal, I., and Iqbal, K. (1986). Occurrence of neuropil threads in the senile human brain and in Alzheimer's disease: a third location of paired helical filaments outside of neurofibrillary tangles and neuritic plaques. Neurosci. Lett. 65, 351-355. doi:10.1016/0304-3940(86)90288-0
19. Bronfman, F. C., Alvarez, A., Morgan, C., and Inestrosa, N. C. (1998). Laminin blocks the assembly of wild-type A beta and the Dutch variant peptide into Alzheimer's fibrils. Amyloid 5, 16-23. doi:10.3109/13506129809007285
20. Bronfman, F. C., Garrido, J., Alvarez, A., Morgan, C., and Inestrosa, N. C. (1996). Laminin inhibits amyloid-beta-peptide fibrillation. Neurosci. Lett. 218, 201-203. doi:10.1016/S0304-3940(96)13147-5
21. Burger, S., Noack, M., Kirazov, L. P., Kirazov, E. P., Naydenov, C. L., Kouznetsova, E., et al. (2009). Vascular endothelial growth factor (VEGF) affects processing of amyloid precursor protein and beta-amyloidogenesis in brain slice cultures derived from transgenic Tg2576 mouse brain. Int. J. Dev. Neurosci. 27, 517-523. doi:10.1016/j.ijdevneu.2009.06.011
22. Burns, A. (1992). Psychiatric phenomena in dementia of the Alzheimer type. Int. Psychogeriatr. 4(Suppl. 1), 43-54. doi:10.1017/S1041610292001145
23. Caffo, M., Caruso, G., Galatioto, S., Meli, F., Cacciola, F., Germano, A., et al. (2008). Immunohistochemical study of the extracellular matrix proteins laminin, fibronectin and type IV collagen in secretory meningiomas. J. Clin. Neurosci. 15, 806-811. doi:10.1016/j.jocn.2007.05.029
24. Candiello, J., Balasubramani, M., Schreiber, E. M., Cole, G. J., Mayer, U., Halfter, W., et al. (2007). Biomechanical properties of native basement membranes. FEBS J. 274, 2897-2908. doi:10.1111/j.1742-4658.2007.05823.x
25. Carare, R. O., Bernardes-Silva, M., Newman, T. A., Page, A. M., Nicoll, J. A., Perry, V. H., et al. (2008). Solutes, but not cells, drain from the brain parenchyma along basement membranes of capillaries and arteries: significance for cerebral amyloid angiopathy and neuroimmunology. Neuropathol. Appl. Neurobiol. 34, 131-144. doi:10.1111/j.1365-2990.2007.00926.x
26. Carare, R. O., Hawkes, C. A., Jeffrey, M., Kalaria, R. N., and Weller, R. O. (2013). Review: cerebral amyloid angiopathy, prion angiopathy, CADASIL and the spectrum of protein elimination failure angiopathies (PEFA) in neurodegenerative disease with a focus on therapy. Neuropathol. Appl. Neurobiol. 39, 593-611. doi:10.1111/nan.12042
27. Carlson, E. C., Brendel, K., Hjelle, J. T., and Meezan, E. (1978). Ultrastructural and biochemical analyses of isolated basement membranes from kidney glomeruli and tubules and brain and retinal microvessels. J. Ultrastruct. Res. 62, 26-53. doi:10.1016/S0022-5320(78)80028-8
28. Castano, E. M., and Frangione, B. (1988). Human amyloidosis, Alzheimer disease and related disorders. Lab. Invest. 58, 122-132.
29. Castillo, G. M., Ngo, C., Cummings, J., Wight, T. N., and Snow, A. D. (1997). Perlecan binds to the beta-amyloid proteins (A beta) of Alzheimer's disease, accelerates A beta fibril formation, and maintains A beta fibril stability. J. Neurochem. 69, 2452-2465. doi:10.1046/j.1471-4159.1997.69062452.x
30. Christov, A., Ottman, J., Hamdheydari, L., and Grammas, P. (2008). Structural changes in Alzheimer's disease brain microvessels. Curr. Alzheimer Res. 5, 392-395. doi:10.2174/156720508785132334
31. Chuang, Y. F., Breitner, J. C., Chiu, Y. L., Khachaturian, A., Hayden, K., Corcoran, C., et al. (2014). Use of diuretics is associated with reduced risk of Alzheimer's disease: the Cache County Study. Neurobiol. Aging. doi:10.1016/j.neurobiolaging.2014.05.002
32. Chung, Y. A., JH, O., Kim, J. Y., Kim, K. J., and Ahn, K. J. (2009). Hypoperfusion and ischemia in cerebral amyloid angiopathy documented by 99mTc-ECD brain perfusion SPECT. J. Nucl. Med. 50, 1969-1974. doi:10.2967/jnumed.109.062315
33. Cotman, S. L., Halfter, W., and Cole, G. J. (2000). Agrin binds to beta-amyloid (Abeta), accelerates abeta fibril formation, and is localized to Abeta deposits in Alzheimer's disease brain. Mol. Cell. Neurosci. 15, 183-198. doi:10.1006/mcne.1999.0816
34. Cserr, H. F., Cooper, D. N., Suri, P. K., and Patlak, C. S. (1981). Efflux of radiolabeled polyethylene glycols and albumin from rat brain. Am. J. Physiol. 240, F319-F328.
35. Dahl, E. (1976). "Microscopic observations on cerebral arteries," in The Cerebral Vessels Wall, eds J. Cervos-Navarro, E. Betz, F. Matakas, and R. Wu¨llenweber (New York: Raven Press), p. 15-21.
36. Dickson, D. W., Farlo, J., Davies, P., Crystal, H., Fuld, P., and Yen, S. H. (1988). Alzheimer's disease. A double-labeling immunohistochemical study of senile plaques. Am. J. Pathol. 132, 86-101.
37. Dohgu, S., Takata, F., Yamauchi, A., Nakagawa, S., Egawa, T., Naito, M., et al. (2005). Brain pericytes contribute to the induction and up-regulation of blood-brain barrier functions through transforming growth factor-beta production 1. Brain Res. 1038, 208-215. doi:10.1016/j.brainres.2005.01.027
38. Esiri, M., Lee, V. M.-Y., and Trojanowski, J. Q. (2004). The Neuropathology of Dementia, 2nd Edn. Cambridge: Cambridge University Press.
39. Farkas, E., and Luiten, P. G. (2001). Cerebral microvascular pathology in aging and Alzheimer's disease. Prog. Neurobiol. 64, 575-611. doi:10.1016/S0301-0082(00)00068-X
40. Gao, S., Hendrie, H. C., Hall, K. S., and Hui, S. (1998). The relationships between age, sex, and the incidence of dementia and Alzheimer disease: a meta-analysis. Arch. Gen. Psychiatry 55, 809-815. doi:10.1001/archpsyc.55.9.809
41. Giannakopoulos, P., Hof, P. R., Michel, J. P., Guimon, J., and Bouras, C. (1997). Cerebral cortex pathology in aging and Alzheimer's disease: a quantitative survey of large hospital-based geriatric and psychiatric cohorts. Brain Res. Brain Res. Rev. 25, 217-245. doi:10.1016/S0165-0173(97)00023-4
42. Goldbrunner, R. H., Bernstein, J. J., and Tonn, J. C. (1999). Cell-extracellular matrix interaction in glioma invasion. Acta Neurochir. 141, 295-305, discussion 4-5. doi:10.1007/s007010050301
43. Grundke-Iqbal, I., Iqbal, K., Tung, Y. C., Quinlan, M., Wisniewski, H. M., and Binder, L. I. (1986). Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc. Natl. Acad. Sci. U.S.A. 83, 4913-4917. doi:10.1073/pnas.83.13.4913
44. Guo, Z., Fratiglioni, L., Zhu, L., Fastbom, J., Winblad, B., and Viitanen, M. (1999). Occurrence and progression of dementia in a community population aged 75 years and older: relationship of antihypertensive medication use. Arch. Neurol. 56, 991-996. doi:10.1001/archneur.56.8.991
45. Haag, M. D., Hofman, A., Koudstaal, P. J., Breteler, M. M., and Stricker, B. H. (2009a). Duration of antihypertensive drug use and risk of dementia: a prospective cohort study. Neurology 72, 1727-1734. doi:10.1212/01.wnl.0000345062.86148.3f
46. Haag, M. D., Hofman, A., Koudstaal, P. J., Stricker, B. H., and Breteler, M. M. (2009b). Statins are associated with a reduced risk of Alzheimer disease regardless of lipophilicity. The Rotterdam Study. J. Neurol. Neurosurg. Psychiatr. 80, 13-17. doi:10.1136/jnnp.2008.150433
47. Haan, J., Hardy, J. A., and Roos, R. A. (1991). Hereditary cerebral hemorrhage with amyloidosis - Dutch type: its importance for Alzheimer research. Trends Neurosci. 14, 231-234. doi:10.1016/0166-2236(91)90120-J
48. Hagg, T., Muir, D., Engvall, E., Varon, S., and Manthorpe, M. (1989). Laminin-like antigen in rat CNS neurons: distribution and changes upon brain injury and nerve growth factor treatment. Neuron 3, 721-732. doi:10.1016/0896-6273(89)90241-9
49. Haglund, M., Passant, U., Sjobeck, M., Ghebremedhin, E., and Englund, E. (2006). Cerebral amyloid angiopathy and cortical microinfarcts as putative substrates of vascular dementia. Int. J. Geriatr. Psychiatry 21, 681-687. doi:10.1002/gps.1550
50. Halfter, W., Candiello, J., Hu, H., Zhang, P., Schreiber, E., and Balasubramani, M. (2013). Protein composition and biomechanical properties of in vivo-derived basement membranes. Cell Adh. Migr. 7, 64-71. doi:10.4161/cam.22479
51. Hallmann, R., Horn, N., Selg, M., Wendler, O., Pausch, F., and Sorokin, L. M. (2005). Expression and function of laminins in the embryonic and mature vasculature. Physiol. Rev. 85, 979-1000. doi:10.1152/physrev.00014.2004
52. Hawkes, C. A., Gatherer, M., Sharp, M. M., Dorr, A., Yuen, H. M., Kalaria, R., et al. (2013). Regional differences in the morphological and functional effects of aging on cerebral basement membranes and perivascular drainage of amyloid-beta from the mouse brain. Aging Cell 12, 224-236. doi:10.1111/acel.12045
53. Hawkes, C. A., Hartig, W., Kacza, J., Schliebs, R., Weller, R. O., Nicoll, J. A., et al. (2011). Perivascular drainage of solutes is impaired in the ageing mouse brain and in the presence of cerebral amyloid angiopathy. Acta Neuropathol. 121, 431-443. doi:10.1007/s00401-011-0801-7
54. Hawkes, C. A., Sullivan, P. M., Hands, S., Weller, R. O., Nicoll, J. A., and Carare, R. O. (2012). Disruption of arterial perivascular drainage of amyloid-beta from the brains of mice expressing the human APOE epsilon4 allele. PLoS ONE 7:e41636. doi:10.1371/journal.pone.0041636
55. Herzig, M. C., Van Nostrand, W. E., and Jucker, M. (2006). Mechanism of cerebral beta-amyloid angiopathy: murine and cellular models. Brain Pathol. 16, 40-54. doi:10.1111/j.1750-3639.2006.tb00560.x
56. Herzig, M. C., Winkler, D. T., Burgermeister, P., Pfeifer, M., Kohler, E., Schmidt, S. D., et al. (2004). Abeta is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis. Nat. Neurosci. 7, 954-960. doi:10.1038/nn1302
57. Hunter, D. D., Llinas, R., Ard, M., Merlie, J. P., and Sanes, J. R. (1992). Expression of s-laminin and laminin in the developing rat central nervous system. J. Comp. Neurol. 323, 238-251. doi:10.1002/cne.903230208
58. In't Veld, B. A., Ruitenberg, A., Hofman, A., Stricker, B. H., and Breteler, M. M. (2001). Antihypertensive drugs and incidence of dementia: the Rotterdam Study. Neurobiol. Aging 22, 407-412. doi:10.1016/S0197-4580(00)00241-4
59. Iqbal, K., Liu, F., Gong, C. X., and Grundke-Iqbal, I. (2010). Tau in Alzheimer disease and related tauopathies. Curr. Alzheimer Res. 7, 656-664. doi:10.2174/156720510793611592
60. Jellinger, K. A. (2002). Alzheimer disease and cerebrovascular pathology: an update. J. Neural Trans. 109, 813-836. doi:10.1007/s007020200068
61. Jucker, M., Tian, M., and Ingram, D. K. (1996a). Laminins in the adult and aged brain. Mol. Chem. Neuropathol. 28, 209-218. doi:10.1007/BF02815224
62. Jucker, M., Tian, M., Norton, D. D., Sherman, C., and Kusiak, J. W. (1996b). Laminin alpha 2 is a component of brain capillary basement membrane: reduced expression in dystrophic dy mice. Neuroscience 71, 1153-1161. doi:10.1016/0306-4522(95)00496-3
63. Kalaria, R. N. (1996). Cerebral vessels in ageing and Alzheimer's disease. Pharmacol. Ther. 72, 193-214. doi:10.1016/S0163-7258(96)00116-7
64. Kalluri, R. (2003). Basement membranes: structure, assembly and role in tumour angiogenesis. Nat. Rev. Cancer 3, 422-433. doi:10.1038/nrc1094
65. Khachaturian, A. S., Zandi, P. P., Lyketsos, C. G., Hayden, K. M., Skoog, I., Norton, M. C., et al. (2006). Antihypertensive medication use and incident Alzheimer disease: the Cache County Study. Arch. Neurol. 63, 686-692. doi:10.1001/archneur.63.5.noc60013
66. Khoshnoodi, J., Pedchenko, V., and Hudson, B. G. (2008). Mammalian collagen IV. Microsc. Res. Tech. 71, 357-370. doi:10.1002/jemt.20564
67. Kiuchi, Y., Isobe, Y., Fukushima, K., and Kimura, M. (2002a). Disassembly of amyloid beta-protein fibril by basement membrane components. Life Sci. 70, 2421-2431. doi:10.1016/S0024-3205(02)01501-1
68. Kiuchi, Y., Isobe, Y., and Fukushima, K. (2002b). Type IV collagen prevents amyloid beta-protein fibril formation. Life Sci. 70, 1555-1564. doi:10.1016/S0024-3205(01)01528-4
69. Larson, E. B., Shadlen, M. F., Wang, L., McCormick, W. C., Bowen, J. D., Teri, L., et al. (2004). Survival after initial diagnosis of Alzheimer disease. Ann. Intern. Med. 140, 501-509. doi:10.7326/0003-4819-140-7-200404060-00008
70. Launer, L. J., Ross, G. W., Petrovitch, H., Masaki, K., Foley, D., White, L. R., et al. (2000). Midlife blood pressure and dementia: the Honolulu-Asia aging study. Neurobiol. Aging 21, 49-55. doi:10.1016/S0197-4580(00)00096-8
71. McKee, K. K., Capizzi, S., and Yurchenco, P. D. (2009). Scaffold-forming and adhesive contributions of synthetic laminin-binding proteins to basement membrane assembly. J. Biol. Chem. 284, 8984-8994. doi:10.1074/jbc.M809719200
72. Miao, J., Xu, F., Davis, J., Otte-Holler, I., Verbeek, M. M., and Van Nostrand, W. E. (2005). Cerebral microvascular amyloid beta protein deposition induces vascular degeneration and neuroinflammation in transgenic mice expressing human vasculotropic mutant amyloid beta precursor protein. Am. J. Pathol. 167, 505-515. doi:10.1016/S0002-9440(10)62993-8
73. Miner, J. H. (1999). Renal basement membrane components. Kidney Int. 56, 2016-2024. doi:10.1046/j.1523-1755.1999.00785.x
74. Miner, J. H., and Yurchenco, P. D. (2004). Laminin functions in tissue morphogenesis. Annu. Rev. Cell Dev. Biol. 20, 255-284. doi:10.1146/annurev.cellbio.20.010403.094555
75. Miyakawa, T., Shimoji, A., Kuramoto, R., and Higuchi, Y. (1982). The relationship between senile plaques and cerebral blood vessels in Alzheimer's disease and senile dementia. Morphological mechanism of senile plaque production. Virchows Arch. B Cell Pathol. 40, 121-129. doi:10.1007/BF02932857
76. Natte, R., Maat-Schieman, M. L., Haan, J., Bornebroek, M., Roos, R. A., and van Duinen, S. G. (2001). Dementia in hereditary cerebral hemorrhage with amyloidosis-Dutch type is associated with cerebral amyloid angiopathy but is independent of plaques and neurofibrillary tangles. Ann. Neurol. 50, 765-772. doi:10.1002/ana.10040
77. Noonan, D. M., and Hassell, J. R. (1993). Perlecan, the large low-density proteoglycan of basement membranes: structure and variant forms. Kidney Int. 43, 53-60. doi:10.1038/ki.1993.10
78. Ohrui, T., Matsui, T., Yamaya, M., Arai, H., Ebihara, S., Maruyama, M., et al. (2004). Angiotensin-converting enzyme inhibitors and incidence of Alzheimer's disease in Japan. J. Am. Geriatr. Soc. 52, 649-650. doi:10.1111/j.1532-5415.2004.52178_7.x
79. Patton, R. L., Kalback, W. M., Esh, C. L., Kokjohn, T. A., Van Vickle, G. D., Luehrs, D. C., et al. (2006). Amyloid-beta peptide remnants in AN-1792-immunized Alzheimer's disease patients: a biochemical analysis. Am. J. Pathol. 169, 1048-1063.
80. Perlmutter, L. S. (1994). Microvascular pathology and vascular basement membrane components in Alzheimer's disease. Mol. Neurobiol. 9, 33-40. doi:10.1007/BF02816103
81. Perlmutter, L. S., Myers, M. A., and Barron, E. (1994). Vascular basement membrane components and the lesions of Alzheimer's disease: light and electron microscopic analyses. Microsc. Res. Tech. 28, 204-215. doi:10.1002/jemt.1070280305
82. Perris, R. (1997). The extracellular matrix in neural crest-cell migration. Trends Neurosci. 20, 23-31. doi:10.1016/S0166-2236(96)10063-1
83. Pfeifer, L. A., White, L. R., Ross, G. W., Petrovitch, H., and Launer, L. J. (2002a). Cerebral amyloid angiopathy and cognitive function: the HAAS autopsy study. Neurology 58, 1629-1634. doi:10.1212/WNL.58.11.1629
84. Pfeifer, M., Boncristiano, S., Bondolfi, L., Stalder, A., Deller, T., Staufenbiel, M., et al. (2002b). Cerebral hemorrhage after passive anti-Abeta immunotherapy. Science 298, 1379. doi:10.1126/science.1078259
85. Rasi, K., Hurskainen, M., Kallio, M., Staven, S., Sormunen, R., Heape, A. M., et al. (2010). Lack of collagen XV impairs peripheral nerve maturation and, when combined with laminin-411 deficiency, leads to basement membrane abnormalities and sensorimotor dysfunction. J. Neurosci. 30, 14490-14501. doi:10.1523/JNEUROSCI.2644-10.2010
86. Roher, A. E., Kuo, Y. M., Esh, C., Knebel, C., Weiss, N., Kalback, W., et al. (2003). Cortical and leptomeningeal cerebrovascular amyloid and white matter pathology in Alzheimer's disease. Mol. Med. 9, 112-122.
87. Schley, D., Carare-Nnadi, R., Please, C. P., Perry, V. H., and Weller, R. O. (2006). Mechanisms to explain the reverse perivascular transport of solutes out of the brain. J. Theor. Biol. 238, 962-974. doi:10.1016/j.jtbi.2005.07.005
88. Scholz, W. (1938). Studien zur pathologie der Hirgefa¨sse. II. Die drusige entartung der Hirnarterien und capillaren. Z. Ges. Neurol. Psychiatr. 162, 694-715. doi:10.1007/BF02890989
89. Shah, N. S., Vidal, J. S., Masaki, K., Petrovitch, H., Ross, G. W., Tilley, C., et al. (2012). Midlife blood pressure, plasma beta-amyloid, and the risk for Alzheimer disease: the Honolulu Asia Aging Study. Hypertension 59, 780-786. doi:10.1161/HYPERTENSIONAHA.111.178962
90. Shimizu, H., Ghazizadeh, M., Sato, S., Oguro, T., and Kawanami, O. (2009). Interaction between beta-amyloid protein and heparan sulfate proteoglycans from the cerebral capillary basement membrane in Alzheimer's disease. J. Clin. Neurosci. 16, 277-282. doi:10.1016/j.jocn.2008.04.009
91. Shin, H. K., Jones, P. B., Garcia-Alloza, M., Borrelli, L., Greenberg, S. M., Bacskai, B. J., et al. (2007). Age-dependent cerebrovascular dysfunction in a transgenic mouse model of cerebral amyloid angiopathy. Brain 130(Pt 9), 2310-2319. doi:10.1093/brain/awm156
92. Sink, K. M., Leng, X., Williamson, J., Kritchevsky, S. B., Yaffe, K., Kuller, L., et al. (2009). Angiotensin-converting enzyme inhibitors and cognitive decline in older adults with hypertension: results from the Cardiovascular Health Study. Arch. Intern. Med. 169, 1195-1202. doi:10.1001/archinternmed.2009.175
93. Sixt, M., Engelhardt, B., Pausch, F., Hallmann, R., Wendler, O., and Sorokin, L. M. (2001). Endothelial cell laminin isoforms, laminins 8 and 10, play decisive roles in T cell recruitment across the blood-brain barrier in experimental autoimmune encephalomyelitis. J. Cell Biol. 153, 933-946. doi:10.1083/jcb.153.5.933
94. Sorokin, L. (2010). The impact of the extracellular matrix on inflammation. Nat. Rev. Immunol. 10, 712-723. doi:10.1038/nri2852
95. Suzuki, N., Iwatsubo, T., Odaka, A., Ishibashi, Y., Kitada, C., and Ihara, Y. (1994). High tissue content of soluble beta 1-40 is linked to cerebral amyloid angiopathy. Am J Pathol 145(2):452-460.
96. Szentistvanyi, I., Patlak, C. S., Ellis, R. A., and Cserr, H. F. (1984). Drainage of interstitial fluid from different regions of rat brain. Am. J. Physiol. 246(6 Pt 2), F835-F844.
97. Tanzi, R. E. (2012). The genetics of Alzheimer disease. Cold Spring Harb. Perspect. Med. 2, a006296. doi:10.1101/cshperspect.a006296
98. Teeling, J. L., Carare, R. O., Glennie, M. J., and Perry, V. H. (2012). Intracerebral immune complex formation induces inflammation in the brain that depends on Fc receptor interaction. Acta Neuropathol. 124, 479-490. doi:10.1007/s00401-012-0995-3
99. Thyboll, J., Kortesmaa, J., Cao, R., Soininen, R., Wang, L., Iivanainen, A., et al. (2002). Deletion of the laminin alpha4 chain leads to impaired microvessel maturation. Mol. Cell. Biol. 22, 1194-1202. doi:10.1128/MCB.22.4.1194-1202.2002
100. Tian, J., Shi, J., Smallman, R., Iwatsubo, T., and Mann, D. M. (2006). Relationships in Alzheimer's disease between the extent of Abeta deposition in cerebral blood vessel walls, as cerebral amyloid angiopathy, and the amount of cerebrovascular smooth muscle cells and collagen. Neuropathol. Appl. Neurobiol. 32, 332-340. doi:10.1111/j.1365-2990.2006.00732.x
101. Timpl, R. (1996). Macromolecular organization of basement membranes. Curr. Opin. Cell Biol. 8, 618-624. doi:10.1016/S0955-0674(96)80102-5
102. Timpl, R., and Brown, J. C. (1996). Supramolecular assembly of basement membranes. Bioessays 18, 123-132. doi:10.1002/bies.950180208
103. Vinters, H. V. (1987). Cerebral amyloid angiopathy. A critical review. Stroke 18, 311-324. doi:10.1161/01.STR.18.2.311
104. Vinters, H. V., Wang, Z. Z., and Secor, D. L. (1996). Brain parenchymal and microvascular amyloid in Alzheimer's disease. Brain Pathol. 6, 179-195. doi:10.1111/j.1750-3639.1996.tb00799.x
105. Vogels, O. J., Broere, C. A., ter Laak, H. J., ten Donkelaar, H. J., Nieuwenhuys, R., and Schulte, B. P. (1990). Cell loss and shrinkage in the nucleus basalis Meynert complex in Alzheimer's disease. Neurobiol. Aging 11, 3-13. doi:10.1016/0197-4580(90)90056-6
106. Wang, P., and Olbricht, W. L. (2011). Fluid mechanics in the perivascular space. J. Theor. Biol. 274, 52-57. doi:10.1016/j.jtbi.2011.01.014
107. Weber, M. (1992). Basement membrane proteins. Kidney Int. 41, 620-628. doi:10.1038/ki.1992.95
108. Weller, R. O., Massey, A., Newman, T. A., Hutchings, M., Kuo, Y. M., and Roher, A. E. (1998). Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease. Am. J. Pathol. 153, 725-733. doi:10.1016/S0002-9440(10)65616-7
109. Weller, R. O., Subash, M., Preston, S. D., Mazanti, I., and Carare, R. O. (2008). Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer's disease. Brain Pathol. 18, 253-266. doi:10.1111/j.1750-3639.2008.00133.x
110. Whitehouse, P. J., Price, D. L., Struble, R. G., Clark, A. W., Coyle, J. T., and Delon, M. R. (1982). Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science 215, 1237-1239. doi:10.1126/science.7058341
111. Wilcock, D. M., Rojiani, A., Rosenthal, A., Subbarao, S., Freeman, M. J., Gordon, M. N., et al. (2004). Passive immunotherapy against Abeta in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased vascular amyloid and microhemorrhage. J. Neuroinflammation 1, 24. doi:10.1186/1742-2094-1-24
112. Wisniewski, H. M., and Wegiel, J. (1994). Beta-amyloid formation by myocytes of leptomeningeal vessels. Acta Neuropathol. 87, 233-241. doi:10.1007/BF00296738
113. Wisniewski, H. M., Wegiel, J., and Kotula, L. (1996). Review. David Oppenheimer Memorial Lecture 1995: some neuropathological aspects of Alzheimer's disease and its relevance to other disciplines. Neuropathol. Appl. Neurobiol. 22, 3-11. doi:10.1111/j.1365-2990.1996.tb00839.x
114. Wu, C., Ivars, F., Anderson, P., Hallmann, R., Vestweber, D., Nilsson, P., et al. (2009). Endothelial basement membrane laminin alpha5 selectively inhibits T lymphocyte extravasation into the brain. Nat. Med. 15, 519-527. doi:10.1038/nm.1957
115. Wyss-Coray, T., Lin, C., Sanan, D. A., Mucke, L., and Masliah, E. (2000). Chronic overproduction of transforming growth factor-beta1 by astrocytes promotes Alzheimer's disease-like microvascular degeneration in transgenic mice. Am. J. Pathol. 156, 139-150. doi:10.1016/S0002-9440(10)64713-X
116. Yousif, L. F., Di Russo, J., and Sorokin, L. (2013). Laminin isoforms in endothelial and perivascular basement membranes. Cell Adh. Migr. 7, 101-110. doi:10.4161/cam.22680
117. Yurchenco, P. D., and Schittny, J. C. (1990). Molecular architecture of basement membranes. FASEB J. 4, 1577-1590.
118. Zarow, C., Barron, E., Chui, H. C., and Perlmutter, L. S. (1997). Vascular basement membrane pathology and Alzheimer's disease. Ann. N. Y. Acad. Sci. 826, 147-160. doi:10.1111/j.1749-6632.1997.tb48467.x
119. Zhang, E. T., Richards, H. K., Kida, S., and Weller, R. O. (1992). Directional and compartmentalised drainage of interstitial fluid and cerebros- pinal fluid from the rat brain. Acta Neuropathol. 83, 233-239. doi:10.1007/BF00296784
120. Zlokovic, B. V. (2008). The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 57, 178-201. doi:10.1016/j.neuron.2008.01.003